229 related articles for article (PubMed ID: 25077440)
1. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
3. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.
Watanabe A; Suzuki H; Yokobori T; Altan B; Kubo N; Araki K; Wada S; Mochida Y; Sasaki S; Kashiwabara K; Hosouchi Y; Kuwano H
Cancer Sci; 2013 Nov; 104(11):1427-32. PubMed ID: 23919841
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.
Techasen A; Namwat N; Loilome W; Bungkanjana P; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Med Oncol; 2012 Dec; 29(5):3083-91. PubMed ID: 22903530
[TBL] [Abstract][Full Text] [Related]
5. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
[TBL] [Abstract][Full Text] [Related]
6. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
[TBL] [Abstract][Full Text] [Related]
7. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
8. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J
PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma.
Ryu HS; Chung JH; Lee K; Shin E; Jing J; Choe G; Kim H; Xu X; Lee HE; Kim DG; Lee H; Jang JJ
Hum Pathol; 2012 Dec; 43(12):2360-70. PubMed ID: 23084587
[TBL] [Abstract][Full Text] [Related]
11. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
12. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
[TBL] [Abstract][Full Text] [Related]
13. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma.
Duangkumpha K; Techasen A; Loilome W; Namwat N; Thanan R; Khuntikeo N; Yongvanit P
Tumour Biol; 2014 Oct; 35(10):9667-76. PubMed ID: 24969562
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of snail expression in hilar cholangiocarcinoma.
Kong D; Liang J; Li R; Liu S; Wang J; Zhang K; Chen D
Braz J Med Biol Res; 2012 Jul; 45(7):617-24. PubMed ID: 22570087
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma.
Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T
Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683
[TBL] [Abstract][Full Text] [Related]
17. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma.
Gu MJ; Choi JH
J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
[TBL] [Abstract][Full Text] [Related]
20. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]